Lord’s partners with CMET to develop AI-based breast cancer detection device

Lord’s Mark Industries Limited has entered into a technology transfer agreement with the Center for Materials in Electronic Technology (CMET) to produce artificial intelligence-powered radiation-free breast screening wearable devices for early detection of breast cancer.India has the third highest new incidence of breast cancer in the world after China and the United States, with the disease accounting for more than 26% of all cancers in women in the country. The global breast cancer market will be worth US$4,882.14 million in 2024 and is expected to reach US$12,880.85 million by 2035, with a compound annual growth rate of 9.22%1. Grand View Research emphasizes that diagnostics is the leading area driven by demand for early detection, while Future Market Insights estimates the screening and diagnostics market size to be US$505-5.86 billion in 2025, and is expected to reach US$10.5-11.36 billion by 2033-20353.The wearable device combines high-precision thermal sensors with AI-driven temperature mapping to identify early anomalies in a non-invasive, radiation-free way. The collaboration combines CMET’s R&D expertise with Lord’s Mark’s manufacturing scale and distribution capabilities to accelerate local medical technology innovation.Main features and advantages

The device eliminates radiation exposure and discomfort, expands access outside of hospital settings, and provides reliable AI-driven detection insights, representing a significant advancement over traditional mammography.With this move, Lord’s Mark strengthens its long-term commitment to advancing accessible, AI-led healthcare solutions, positioning itself at the forefront of scalable preventive diagnostics in India.Commenting on the partnership with CMET, Sachidanand Upadhyay, Managing Director, Lord’s Mark Industries Limited said: “This collaboration marks a decisive step in our journey to create globally competitive homegrown healthcare technology. By combining CMET’s scientific expertise with Lord’s Mark’s manufacturing prowess, we are enabling a new paradigm in preventive diagnostics – non-invasive, AI-driven and truly accessible. Our vision is to reduce barriers to early detection and provide safer and smarter screening solutions to women across India. This is more than a product initiative; it’s a commitment to scalable, impact-led healthcare innovation. “Lord’s Mark Industries Limited said that through this initiative, it aims to enhance its focus on technology-led healthcare manufacturing with a focus on smart, inclusive and impact-driven solutions aimed at making early detection safer, simpler and more accessible. The company plans to commercialize the product for mass breast cancer screening in India and, over time, expand its product into international markets through its growing global network. According to the company, this effort is also part of a wider ambition to bring healthcare technologies developed in India to the world. Lord’s Mark Industries Limited said it aims to make screening solutions affordable so that more women in India and abroad can get tested regularly. The company said the program also aims to raise awareness about breast cancer and highlight the role of early detection in improving treatment outcomes. The company added that it expects the product to be commercially available globally by the end of this year.For more information, please visit website.refer to: Disclaimer – The above content is non-editorial and TIL hereby disclaims any and all warranties, express or implied, in connection therewith and does not warrant, guarantee or necessarily endorse any content.